Symbiomics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Series A
- Investors
-
10
Symbiomics General Information
Description
Operator of a biotechnology company intended to focus on developing biological products containing efficient microbes for multiple applications in agriculture and the environment. The company's services include translating cutting-edge scientific knowledge into products that improve plant performance and reduce environmental degradation, performing notable work, and becoming a global reference in the biological market by developing innovative products and technologies, enabling farmers to do sustainable agricultural production through the use of organic products.
Contact Information
Website
www.symbiomics.com.brCorporate Office
- Rodovia José Carlos Daux, 6977
- Santo Antonio de Lisboa
- Florianópolis, Santa Catarina 88050-000
- Brazil
Corporate Office
- Rodovia José Carlos Daux, 6977
- Santo Antonio de Lisboa
- Florianópolis, Santa Catarina 88050-000
- Brazil
Symbiomics Timeline
Symbiomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 01-Jun-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Dec-2023 | Completed | Generating Revenue | |||
| 1. Seed Round | 27-Jan-2023 | $1.92M | $1.92M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Symbiomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Symbiomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Symbiomics Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boldt Capital Management | PE/Buyout | Minority | ||
| Calcário Cazanga - Mineração João Vaz Sobrinho | Corporation | Minority | ||
| Corteva | Corporation | Minority | ||
| Ducera Growth Ventures | Venture Capital | Minority | ||
| Arar Capital | Venture Capital | Minority |
Symbiomics FAQs
-
When was Symbiomics founded?
Symbiomics was founded in 2021.
-
Where is Symbiomics headquartered?
Symbiomics is headquartered in Florianópolis, Brazil.
-
What is the size of Symbiomics?
Symbiomics has 29 total employees.
-
What industry is Symbiomics in?
Symbiomics’s primary industry is Other Agriculture.
-
Is Symbiomics a private or public company?
Symbiomics is a Private company.
-
What is Symbiomics’s current revenue?
The current revenue for Symbiomics is .
-
How much funding has Symbiomics raised over time?
Symbiomics has raised $1.92M.
-
Who are Symbiomics’s investors?
Boldt Capital Management, Calcário Cazanga - Mineração João Vaz Sobrinho, Corteva, Ducera Growth Ventures, and Arar Capital are 5 of 10 investors who have invested in Symbiomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
